Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
5.06
-0.01 (-0.20%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Alumis Employees
As of December 31, 2024, Alumis had 170 total employees, including 168 full-time and 2 part-time employees. The number of employees increased by 61 or 55.96% compared to the previous year.
Employees
170
Change (1Y)
61
Growth (1Y)
55.96%
Revenue / Employee
n/a
Profits / Employee
-$1,730,782
Market Cap
272.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170 | 61 | 55.96% |
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ALMS News
- 2 days ago - ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc. - SLRN - Business Wire
- 4 days ago - Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
- 11 days ago - Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
- 14 days ago - Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger - GlobeNewsWire
- 25 days ago - Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan - GlobeNewsWire
- 4 weeks ago - Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 5 weeks ago - Alumis to Present at Leerink's 2025 Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis - GlobeNewsWire